If you have a separate qualifying indication, meaning type 2 diabetes or clinically significant obesity, and you dont have a history of significant gastroparesis or GI dysmotility, its entirely reasonable to discuss GLP-1 receptor agonists with your doctor as a potential treatment for that primary indication, whilst being aware of the chronic pain angle as a potential secondary benefit
When guided by a medical provider, these treatments contribute to long-term metabolic healthsomething diet and exercise alone cant always deliver
The most common and severe form, infantile or nephropathic cystinosis, constitutes roughly 95% of all cases and is associated with kidney failure at 910 years of age [2]
Their Perspectives article is full of false analogies, mischaracterizations, and unprofessional attacks on Casss integrity
LegitScript is an independent auditor that vets online health services